Tango Appoints Rob Eroh as Chief Product Officer and Cole Bowman as Chief Revenue Officer
DALLAS, April 08, 2026 (GLOBE NEWSWIRE) -- Tango, the leading provider of…
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 06, 2026 17:33 ET | Source: Tango Therapeutics Sub, Inc BOSTON,…
